Exploring IL-17 Therapies: Efficacy on Enthesitis

This chapter reviews the latest advancements in IL-17 therapies for psoriatic arthritis, including a focus on medications like bimikizumab and secukinumab. It details a study showcasing significant improvements in enthesial tissue inflammation among patients receiving secukinumab, reinforcing the efficacy of IL-17 inhibitors.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app